Top compounds associated with response to UNC79


Feature Type Standardized
Nominal ANOVA
mRNA CCT036477 CTRPv2 pan-cancer AAC 0.18 3e-07
mRNA necrosulfonamide CTRPv2 pan-cancer AAC 0.22 3e-07
mRNA BRD-K28456706 CTRPv2 pan-cancer AAC 0.21 3e-07
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 3e-07
mRNA Cetuximab GDSC1000 pan-cancer AAC -0.17 6e-07
mRNA KPT185 CTRPv2 pan-cancer AAC 0.21 6e-07
mRNA NVP-BEZ235 GDSC1000 pan-cancer AAC -0.19 6e-07
mRNA GSK1070916 GDSC1000 pan-cancer AAC 0.16 1e-06
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 1e-06
mRNA Topotecan CTRPv2 pan-cancer AAC 0.17 1e-06
Download CSV